11/15/2009 Sunday, November 15, 2009 (Irvine, California) Today StockRing.com Recommendation is to "SUPER BUY"for VARIAN MED SYS IN (NYSE:VAR) Stock.
VAR stock opening price was $45.23 per share.
Current price of NYSE:VAR Stock is $45.22 per share
and it is
$+0.19, (+0.42%) today
and it was trading in the daily range of $44.90 - 45.58 per share.
Current Bid Price for (NYSE:VAR) stock is $44.32 and the Ask Price is $46.14. In the last 52 weeks
VAR stock was trading in the range of $27.10 - 44.86. 50-Day Moving Average for (NYSE:VAR) stock is
$41.6636 and 200-Day Moving Average is $37.912. On average analysts predict that One Year Target Estimated price for
(NYSE:VAR) stock is $47.00.
VARIAN MED SYS IN (NYSE:VAR)Market capitalization is $5.621B. (NYSE:VAR) stock average daily volume is
1,284,230 shares per day.
However, on last trading session of Nov 13, 2009
VAR stock traded 737,295 shares.
Also The Short Ratio for (NYSE:VAR) stock is 9.90.
On previous trading session VAR Stock closed at $45.03 per share.
Last year VARIAN MED SYS IN (NYSE:VAR) before taxes (EBITDA) (ttm) earned $517.7M on total revenue of $2.214B.
Earnings Per Share - EPS (ttm) for VAR stock is 2.552.
Also, (NYSE:VAR) Stock Price Per Earnings ratio - P/E is 17.64.
Thus, (NYSE:VAR) Stock Price/Sales (ttm) ratio is 2.53 and Price/Book (mrq) ratio is 4.27.
(NYSE:VAR) Stock does NOT PAY any dividend.
So at this time (NYSE:VAR) Stock maintains Trailing Annual Dividend Rate at 0.00
.
StockRing Recommendations for VARIAN MED SYS IN (NYSE:VAR) Stock are updated daily here
VARIAN MED SYS INC (NYSE: VAR) Company Information
Varian Medical Systems Inc.
3100 Hansen Way
Palo Alto, CA 94304-1038
United States - Map
Phone: 650-493-4000
Fax: 650-424-6822
Web Site: http://www.varian.com
VARIAN MED SYS INC (NYSE: VAR) DETAILS
VARIAN MED SYS INC (NYSE: VAR) Index Membership: S&P 500
S&P 1500 Super Comp
VARIAN MED SYS INC (NYSE: VAR) Sector: Healthcare
VARIAN MED SYS INC (NYSE: VAR) Industry: Medical Appliances & Equipment
VARIAN MED SYS INC (NYSE: VAR) Full Time Employees: 5,100
VARIAN MED SYS INC (NYSE: VAR) BUSINESS SUMMARY
Varian Medical Systems, Inc. provides cancer therapy systems worldwide. Its Oncology Systems segment designs, manufactures, sells, and services hardware and software products to treat cancer with radiation, including linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, and accessories, as well as information management, treatment planning, and image processing software. This segment?s products enable oncology departments to perform conventional radiotherapy, intensity modulated radiation therapy, image guided radiation therapy, and stereotactic radiotherapy, as well as brachytherapy techniques. Oncology Systems segment markets its products to cancer treatment clinics, university research and community hospitals, private and governmental institutions, healthcare agencies, doctors? offices, and cancer care clinics. The company?s X-ray Products segment designs, manufactures, and markets X-ray imaging components and subsystems, such as X-ray tubes for computed tomography, scanning, radioscopic/fluoroscopic imaging, mammography, and special procedures and industrial applications; and flat panel detectors for filmless X-ray imaging. This segment sells its products to imaging system original equipment manufacturers. Varian Medical Systems also provides Linatron X-ray accelerators and IntellX imaging product for security and inspection purposes; designs, manufactures, and integrates products and systems for delivering proton therapy; and develops technologies in the areas of digital X-ray imaging technology, volumetric and functional imaging, improved X-ray sources, and technology for security and cargo screening applications. It has a strategic development agreement with Calypso Medical Technologies, Inc. to develop products integrating Calypso System with the company?s radiotherapy treatment technologies. The company, formerly known as Varian Associates, Inc., was founded in 1948 and is headquartered in Palo Alto, California.
VARIAN MED SYS INC (NYSE: VAR) KEY EXECUTIVES, SALARIES and BONUSES
Mr. Timothy E. Guertin , Age: 60
Chief Exec. Officer, Pres and Exec. Director Salary: $ 2.50M Bonus: $ 6.85M
Ms. Elisha W. Finney , Age: 47
Chief Financial Officer and Corp. Sr. VP of Fin. Salary: $ 1.29M Bonus: $ 3.72M
Mr. Robert H. Kluge , Age: 63
Corp. Sr. VP and Pres of X-Ray Products Salary: $ 808.00K Bonus: $ 10.14M
Mr. Dow R. Wilson , Age: 45
Corp. Exec. VP and Pres of Oncology Systems Salary: $ 1.84M Bonus: $ 142.00K
Mr. John W. Kuo , Age: 46
Corp. VP, Corp. Sec. and Gen. Counsel Salary: $ 764.00K Bonus: $ 1.07M
US Researchers have reported that image-guided RapidArc radiotherapy from Varian Medical Systems has clinical advantages over earlier fixed-beam approaches to stereotactic radiosurgery (SRS) or ...
PALO ALTO, Calif., Nov. 12 /PRNewswire-FirstCall/ -- Researchers from the University of California, Irvine Medical Center reported last week that image-guided RapidArc® radiotherapy from Varian ...
CHICAGO , Nov. 10 /PRNewswire-FirstCall/ -- Clinicians using RapidArc® radiotherapy technology for fast, precise, non-invasive cancer treatments have found that they are able to substantially ...
Analysts were expecting Medical Action Industries Inc. (MDCI) [Chart - News - Analysis] to report earnings of $0.21 for last quarter, but MDCI beat expectations with actual earnings of $0.25---4 ...
Analysts were expecting Smith & Nephew plc (SNN) [Chart - News - Analysis] to report earnings of $0.66 for last quarter, but SNN beat expectations with actual earnings of $0.84---18 cents above ...
Traders watch earnings announcements keenly, as changes in a company's financials can be a good indication whether a company is on the right track, or headed the wrong way. Smith & Nephew plc (SNN ...
President and CEO of Varian Medical Systems Inc. (VAR) Timothy E Guertin sells 60,000 shares of VAR on 11/02/2009 at an average price of $43.27 a share. Varian Medical Systems Inc. of Palo Alto ...
ScandiDos Sells 100th Delta4(R) PT Unit as Adoption of Rotational Therapy Cancer Treatment Increases Premier Chicago Hospital selects ScandiDos to provide QA for RapidArc(TM) CHICAGO, Nov. 3 ...
Combined Technology Platforms May Lead to More Accurate Radiation Delivery and Fewer Side Effects SEATTLE--(Business Wire)-- Calypso Medical Technologies, Inc., a developer of real-time ...
Carving Up U.K.'s Banks Wall Street Journal The most exotic risk they face is probably stock-market risk, because of their hefty equity holdings. VaR can be a useful management for these risks, ...
Avon Reports Third-Quarter Results Reuters var. vs vs vs 2009 vs vs 3Q08 3Q08 3Q08 percent 3Q08 3Q08 ------------- ----------- ----------- ------- ------ ------ Latin America $1113.9 5% 18% $192.4 ...
XL Capital Ltd Reports Operating Results (10-Q) GuruFocus.com The VaR associated with the alternative investment portfolio at September 30, 2009 based on a 95% confidence level with a one month holding period, ...
Data and information is provided for informational purposes only, and is not intended
for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any
actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information
found therein.
No comments:
Post a Comment